Ardelyx Announces Departure of Chief Scientific Officer

FREMONT, Calif., Feb. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Ardelyx, Inc. (NASDAQ: ARDX) today announced that Jeremy Caldwell, Ph.D., chief scientific officer, will be leaving the company, effective February 16, 2018, to pursue a position ... Biopharmaceuticals, Personnel Ardelyx, tenapanor, hyperphosphatemia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news